1. Inici
  2. Projectes i Estudis Clínics
  3. Registro de pacientes con asma que comienzan tratamiento con DUPIXENT® (RAPID).

Registro de pacientes con asma que comienzan tratamiento con DUPIXENT® (RAPID).

Dades bàsiques

Protocol:
R668-AS-1885
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2022
Any de finalització:
2026
ESTUDIO OBSERVACIONAL

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

REGENERON PHARMACEUTICALS, INC.

Resultats de l'Assaig Clínic

First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.

Nieto, Antonio; (...); Casanovas, Miguel

Article. 10.1111/all.15374. 2022

  • Open Access.

Food allergy in adolescents: validation of the food allergy independent measure and the EuroPrevall food allergy quality of life questionnaire into Spanish.

Jang, Dah-Tay; (...); Ángel M

Article. 10.15586/aei.v51i2.617. 2023

  • Open Access.

Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled Trial.

Lemoine, Anais; (...); Navas-Lopez, Victor Manuel

Article. 10.3390/nu17010162. 2024

  • Open Access.

Compartir el projecte